Scientists identify promising new target for Alzheimer’s-linked brain inflammation

A multidisciplinary team has developed a selective compound that inhibits an enzyme tied to inflammation in people at genetic risk for Alzheimer’s, while preserving normal brain function and crossing the blood-brain barrier.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup